Juno Therapeutics (JUNO) IPO Continues Higher, Crosses Above $40

Last Friday's IPO for Juno Therapeutics (NASDAQ: JUNO) is continuing hither. After jumping on its debut, shares are up another 14.7% today to $40.04. The IPO priced at $24 and gained 46% on Friday.

You May Also Be Interested In

• IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
• Texas Instruments (TXN) jumps on first above-consensus guide in seven years
• Viking Holdings (VIK) Announces 44M Share IPO at $21-$25/sh